Sawsan Aboul-Fotouh

ketamine barbiturates depression esketamine brexanolone seizure epilepsy addiction pathophysiology lithium drug interactions doxepin desipramine clomipramine nortriptyline amitriptyline imipramine fluvoxamine sertraline escitalopram citalopram paroxetine fluoxetine levomilnacipran desvenlafaxine milnacipran duloxetine venlafaxine snris serotonin norepinephrine reuptake inhibitors buspirone ramelteon alcohol zaleplon zolpidem benzodiazepines (bzds) gabac receptor gaba b receptors gaba a receptors gaba receptors pathophysiology of depression “diagnosis classification of antidepressants tianeptine vortioxetine trazodone agomelatine mirtazapine bupropion hypnotics sedative anxiolytics classification remission algorithm response gamma-hydroxybutyric acid ghb rohypnol gabaergic drugs glutamate/gaba theory major depressive disorder spravato treatment-resistant depression intranasal gaba a positive allosteric modulator postpartum depression allopregnanolone (allo) migraine prophylaxis acute migraine attack ergots triptans pathophysiology of migraine migraine in woman migraine in pregnancy classification of migraine general guidelines for use adverse effects antiepileptics mechanism of action of status epilepticus antiepileptics and pregnancy choice of antiepileptics pathophysiology of epilepsy causes of epilepsy convulsion antiepileptic drugs antiepileptics absence myoclonic tonic-clonic types of epilepsy definition of epilepsy withdrawal intoxication reward pathway pathophysiology of addiction dependence abuse addiction circle fentanyl meperidine pethidine detoxification tramadol morphine heroin analgesics opioid drug therapy of parkinsonism anticholinergic drugs amantadine comt inhibitors maob inhibitors dopamine agonists l-dopa drug-induced parkinsonism dopaminergic drugs travoprost latanoprost betaxolol timolol β- blockers physostigmine echothiopate carbachol pilocarpine carbonic anhydrase inhibitors brimonidine apraclonidine dorzolamide acetazolamide epinephrine dipivefrine) prostaglandins cholinomimetics α2-agonist antiglaucoma drugs amyotrophic lateral sclerosis. multiple sclerosis alzheimer’s disease neurodegenerative diseases neuroleptics dopamine receptor blockers antipsychotic drugs indications serotonin receptor antagonists dopamine theory psychosis schizophrenia atypical antipsychotics typical antipsychotics antipsychotic drugs lithium toxicity mood destabilizers mood stabilizers bipolar disorder motor fluctuation contraindications pharmacokinetics dyskinesia neuroprotection neurotoxicity parkinson's disease levodopa hydroxychloroquine prolonged qt interval clozapine psychotropic drugs covid-19 neuropsychopharmacology